Screener / SEC EDGAR /CIK 0001739940 /10-K filed Feb 26, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks

NYSE Health care · Health Insurance

Cigna CI

New risk paragraphs 22 Not in last year's 10-K Accounting checks 0 worth reading about, of 9 checks Insider buys 0 open-market, last 90 days Filings 2 in the last 30 days

Compare with peers Embed

Excel CSV Email alerts

Filings with the SEC since Dec 26, 2018

1,002 filings, 2 in the last 30 days

SEC filing index

Latest annual report Feb 26, 2026 10-K, period to Dec 31, 2025 Latest quarterly report Nov 5, 2026 10-Q, period to Sep 30, 2026 Latest current report Nov 5, 2026 8-K: Quarterly results

Filed in the last 30 days 2 of 1,002 in all

What the 8-Ks said

1 event in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.

CEO, CFO, COO or CAO: 1 (item 5.02)Auditor change: 0 (item 4.01)Not to be relied on: 0 (item 4.02)Cybersecurity: 0 (item 1.05)Restructuring: 0 (item 2.05)Listing notice: 0 (item 3.01)Impairment: 0 (item 2.06)Debt trigger: 0 (item 2.04)

Mar 3, 2026 CEO, CFO, COO or CAOCEO change “Cordani, who will retire as the CEO of the Company effective July 1, 2026.” 8-K item 5.02 · all documents

From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.

Late filings, 8-K notices and going concern

None found in the last 2 years

All checks

Late filing notices (NT 10-K, NT 10-Q)

No notice in the last 2 years.
8-K notices: listing, impairment, debt trigger

No item 3.01, 2.06 or 2.04 in the last 2 years.
Going-concern language in the 10-K

No statement of substantial doubt in the latest 10-K.

Source: 10-K 0001739940-26-000006 (filed Feb 26, 2026): full text searched

Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.

Every filing on one line

Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)Planned insider sale (Form 144, 10b5-1)

202420252026

All 85 events

Nov 5, 2026 8-K Quarterly results8-K item 2.02
Nov 5, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
Oct 9, 2026 8-K Director or officer change8-K item 5.02
Sep 30, 2026 8-K Regulation FD disclosure8-K item 7.01
Sep 3, 2026 Planned sale Neville Everett (Officer) gave notice of a planned sale of 617 shares worth about $175KForm 144, approximate sale date Sep 3, 2026, under a 10b5-1 plan adopted Jun 2, 2026
Aug 18, 2026 Planned sale Jones Nicole S (Officer) gave notice of a planned sale of 2,677 shares worth about $748KForm 144, approximate sale date Aug 18, 2026, under a 10b5-1 plan adopted May 4, 2026
Aug 4, 2026 Planned sale Jones Nicole S (Officer) gave notice of a planned sale of 19,436 shares worth about $5.4MForm 144, approximate sale date Aug 4, 2026, under a 10b5-1 plan adopted May 4, 2026
Jul 30, 2026 Planned sale Nicole Jones (Executive Vice President, Chief Administrative Officer and Chief Human Resources Officer of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 15,346 shares, runs to May 4, 2027
Jul 30, 2026 Planned sale Everett Neville (Executive Vice President and Special Advisor to the Chief Executive Officer of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,234 shares, runs to Mar 2, 2027
Jul 30, 2026 8-K Quarterly results8-K item 2.02
Jul 30, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
Jun 12, 2026 Planned sale Kates Jamie G (Officer) gave notice of a planned sale of 899 shares worth about $268KForm 144, approximate sale date Jun 12, 2026
May 13, 2026 8-K Regulation FD disclosure8-K item 7.01
May 12, 2026 Planned sale Cordani David (Officer, Director) gave notice of a planned sale of 201,878 shares worth about $59.1MForm 144, approximate sale date May 12, 2026, under a 10b5-1 plan adopted Feb 6, 2026
Apr 30, 2026 Planned sale David Cordani (Chair and Chief Executive Officer of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 212,543 shares, runs to Apr 30, 2027
Apr 30, 2026 8-K Quarterly results8-K item 2.02
Apr 30, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
Apr 27, 2026 8-K Shareholder vote results8-K item 5.07
Mar 3, 2026 Officer CEO changeCordani, who will retire as the CEO of the Company effective July 1, 2026.
Mar 2, 2026 Planned sale Neville Everett (Officer) gave notice of a planned sale of 1,719 shares worth about $497KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted May 22, 2025
Mar 2, 2026 Planned sale Jones Nicole S (Officer) gave notice of a planned sale of 2,307 shares worth about $667KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted May 8, 2025
Feb 27, 2026 8-K Regulation FD disclosure8-K item 7.01
Feb 26, 2026 Planned sale David Cordani (Chairman and Chief Executive Officer of The Cigna Group) ended a 10b5-1 trading planreported in the 10-K, up to 212,543 shares, runs to May 5, 2026
Feb 26, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
Feb 6, 2026 Planned sale Granger Elder (Former Director) gave notice of a planned sale of 6,109 shares worth about $1.8MForm 144, approximate sale date Feb 6, 2026
Feb 5, 2026 8-K Quarterly results8-K item 2.02
Nov 18, 2025 8-K Other events8-K item 8.01
Oct 30, 2025 8-K Quarterly results8-K item 2.02
Oct 30, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
Oct 20, 2025 8-K Director or officer change8-K item 5.02
Sep 4, 2025 8-K Material agreement signed, New debt or obligation, Other events8-K items 1.01, 2.03, 8.01
Sep 2, 2025 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · Contracts Units The Cigna Group may offer and sell the securities listed above from time to time in one or more classes or series and in amounts, at prices and on terms that we may determine at the time of the offering.
Sep 2, 2025 8-K Regulation FD disclosure8-K item 7.01
Jul 31, 2025 Planned sale David Cordani (Chairman and Chief Executive Officer of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 212,543 shares, runs to May 5, 2026
Jul 31, 2025 Planned sale Brian Evanko (President and Chief Operating Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 18,429 shares, runs to May 8, 2026
Jul 31, 2025 Planned sale Nicole Jones (Executive Vice President, Chief Administrative Officer and General Counsel) adopted a 10b5-1 trading planreported in the 10-Q, up to 27,430 shares, runs to May 8, 2026
Jul 31, 2025 Planned sale Everett Neville (Executive Vice President of Strategy and Business Development) adopted a 10b5-1 trading planreported in the 10-Q, up to 3,565 shares, runs to May 8, 2026
Jul 31, 2025 8-K Quarterly results8-K item 2.02
Jul 31, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
Jul 28, 2025 8-K Director or officer change (amended)8-K item 5.02
Jun 2, 2025 8-K Director or officer change8-K item 5.02
May 20, 2025 8-K Regulation FD disclosure8-K item 7.01
May 2, 2025 8-K Quarterly results8-K item 2.02
May 2, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
Apr 28, 2025 8-K Material agreement signed, Material agreement ended, New debt or obligation, Director or officer change, Shareholder vote results8-K items 1.01, 1.02, 2.03, 5.02, 5.07
Apr 18, 2025 8-K Director or officer change8-K item 5.02
Mar 19, 2025 8-K Other events8-K item 8.01
Mar 13, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
Mar 3, 2025 8-K Regulation FD disclosure8-K item 7.01
Feb 27, 2025 Planned sale Retired Maj. Gen. Elder Granger, M.D. (Director of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-K, up to 2,376 shares
Feb 27, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
Jan 30, 2025 8-K Quarterly results8-K item 2.02
Jan 29, 2025 SEC letter SEC asked 3 questions about Form 10-K for the Fiscal Year Ended December 31, 2023letters Oct 22, 2024 to Jan 29, 2025 · Non-GAAP measures, Segments, Revenue
Oct 31, 2024 Planned sale Noelle K. Eder (Executive Vice President, Global Chief Information Officer of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,026 shares
Oct 31, 2024 8-K Quarterly results8-K item 2.02
Oct 31, 2024 10-Q Quarterly report (10-Q)period ended Sep 30, 2024
Sep 3, 2024 8-K Regulation FD disclosure8-K item 7.01
Aug 1, 2024 Planned sale David Cordani (Chairman and Chief Executive Officer of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 59,527 shares, runs to May 5, 2025
Aug 1, 2024 Planned sale Michael Triplett (Special Advisor of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 7,200 shares, runs to Nov 8, 2024
Aug 1, 2024 Planned sale Nicole Jones (Executive Vice President, Chief Administrative Officer and General Counsel of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 8,833 shares, runs to May 5, 2025
Aug 1, 2024 Planned sale William DeLaney (Director of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 2,691 shares, runs to May 6, 2025
Aug 1, 2024 8-K Quarterly results8-K item 2.02
Aug 1, 2024 10-Q Quarterly report (10-Q)period ended Jun 30, 2024
Jun 20, 2024 8-K Director or officer change8-K item 5.02
Jun 6, 2024 8-K Regulation FD disclosure8-K item 7.01
May 2, 2024 Planned sale Noelle Eder (Executive Vice President, Global Chief Information Officer of The Cigna Group) adopted a 10b5-1 trading planreported in the 10-Q, up to 6,408 shares
May 2, 2024 Planned sale Brian Evanko (Executive Vice President, Chief Financial Officer of The Cigna Group and President and Chief Executive Officer, Cigna Healthcare) adopted a 10b5-1 trading planreported in the 10-Q, up to 17,924 shares
May 2, 2024 Planned sale Eric Palmer (Executive Vice President, Enterprise Strategy of The Cigna Group and President and Chief Executive Officer, Evernorth Health Services) adopted a 10b5-1 trading planreported in the 10-Q, up to 17,530 shares
May 2, 2024 Planned sale Elder Granger (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,547 shares
May 2, 2024 8-K Quarterly results8-K item 2.02
May 2, 2024 10-Q Quarterly report (10-Q)period ended Mar 31, 2024
Apr 26, 2024 8-K Material agreement signed, New debt or obligation, Other events8-K items 1.01, 2.03, 8.01
Apr 26, 2024 8-K Shareholder vote results8-K item 5.07
Mar 7, 2024 8-K Regulation FD disclosure8-K item 7.01
Feb 29, 2024 10-K Annual report (10-K)period ended Dec 31, 2023
Feb 15, 2024 8-K Other events8-K item 8.01
Feb 13, 2024 8-K Material agreement signed, New debt or obligation, Regulation FD disclosure, Other events8-K items 1.01, 2.03, 7.01, 8.01
Feb 7, 2024 8-K Other events8-K item 8.01
Feb 2, 2024 8-K Quarterly results8-K item 2.02
Jan 31, 2024 8-K Other events8-K item 8.01
Jan 22, 2024 8-K Director or officer change8-K item 5.02
Jan 17, 2024 8-K Director or officer change8-K item 5.02
Dec 29, 2023 8-K Regulation FD disclosure8-K item 7.01
Dec 11, 2023 8-K Regulation FD disclosure8-K item 7.01
Dec 4, 2023 8-K Regulation FD disclosure8-K item 7.01

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind · each form links to sec.gov

Filed	Form	What it is	Period
Nov 5, 2026	10-Q	Quarterly report	Sep 30, 2026	all files · tables
Nov 5, 2026	8-K	Quarterly results	Nov 5, 2026	all files
Oct 9, 2026	8-K	Director or officer change	Oct 6, 2026	all files
Sep 30, 2026	8-K	Regulation FD disclosure	Sep 30, 2026	all files
Sep 8, 2026	4	Insider trade	Sep 3, 2026	all files
Sep 3, 2026	144	Notice of planned insider sale		all files
Sep 3, 2026	4	Insider trade	Sep 1, 2026	all files
Sep 2, 2026	4	Insider trade	Aug 31, 2026	all files
Aug 20, 2026	4	Insider trade	Jul 9, 2026	all files
Aug 20, 2026	4	Insider trade	Aug 18, 2026	all files
Aug 18, 2026	144	Notice of planned insider sale		all files
Aug 6, 2026	4	Insider trade	Aug 4, 2026	all files
Aug 4, 2026	144	Notice of planned insider sale		all files
Jul 30, 2026	10-Q	Quarterly report	Jun 30, 2026	all files · tables
Jul 30, 2026	8-K	Quarterly results	Jul 30, 2026	all files
Jul 9, 2026	3	New insider	Jul 1, 2026	all files
Jul 9, 2026	3	New insider	Jul 1, 2026	all files
Jul 9, 2026	3	New insider	Jul 1, 2026	all files
Jul 9, 2026	3	New insider	Jul 1, 2026	all files
Jul 9, 2026	3	New insider	Jul 1, 2026	all files
Jun 24, 2026	11-K	Employee plan annual report	Dec 31, 2025	all files
Jun 16, 2026	4	Insider trade	Jun 12, 2026	all files
Jun 12, 2026	144	Notice of planned insider sale		all files
Jun 3, 2026	4	Insider trade	Jun 1, 2026	all files
Jun 2, 2026	4	Insider trade	May 29, 2026	all files
May 14, 2026	4	Insider trade	May 12, 2026	all files
May 13, 2026	8-K	Regulation FD disclosure	May 13, 2026	all files
May 12, 2026	144	Notice of planned insider sale		all files
Apr 30, 2026	10-Q	Quarterly report	Mar 31, 2026	all files · tables
Apr 30, 2026	8-K	Quarterly results	Apr 30, 2026	all files
Apr 29, 2026	SCHEDULE 13G	5%+ owner (passive)		all files
Apr 27, 2026	8-K	Shareholder vote results	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 24, 2026	4	Insider trade	Apr 22, 2026	all files
Apr 3, 2026	3	New insider	Mar 24, 2026	all files
Mar 26, 2026	SCHEDULE 13G/A	5%+ owner (passive), amended		all files
Mar 13, 2026	DEF 14A	Proxy statement	Apr 22, 2026	all files
Mar 13, 2026	ARS	Annual report to shareholders	Dec 31, 2025	all files
Mar 13, 2026	DEFA14A	Extra proxy material		all files
Mar 5, 2026	SCHEDULE 13G/A	5%+ owner (passive), amended		all files
Mar 3, 2026	4	Insider trade	Feb 27, 2026	all files
Mar 3, 2026	4	Insider trade	Feb 27, 2026	all files
Mar 3, 2026	4	Insider trade	Feb 27, 2026	all files
Mar 3, 2026	4	Insider trade	Feb 27, 2026	all files
Mar 3, 2026	4	Insider trade	Feb 27, 2026	all files
Mar 3, 2026	4	Insider trade	Feb 27, 2026	all files
Mar 3, 2026	4	Insider trade	Feb 27, 2026	all files
Mar 3, 2026	4	Insider trade	Feb 27, 2026	all files
Mar 3, 2026	8-K	Director or officer change, Regulation FD disclosure	Feb 25, 2026	all files
Mar 2, 2026	144	Notice of planned insider sale		all files
Mar 2, 2026	144	Notice of planned insider sale		all files
Feb 27, 2026	8-K	Regulation FD disclosure	Feb 27, 2026	all files
Feb 26, 2026	10-K	Annual report	Dec 31, 2025	all files · tables
Feb 6, 2026	144	Notice of planned insider sale		all files
Feb 5, 2026	8-K	Quarterly results	Feb 5, 2026	all files
Dec 2, 2025	4	Insider trade	Nov 28, 2025	all files
Nov 18, 2025	8-K	Other events	Oct 22, 2025	all files
Nov 5, 2025	SCHEDULE 13G/A	5%+ owner (passive), amended		all files
Nov 3, 2025	4	Insider trade	Nov 3, 2025	all files
Oct 30, 2025	10-Q	Quarterly report	Sep 30, 2025	all files · tables
Oct 30, 2025	8-K	Quarterly results	Oct 30, 2025	all files
Oct 20, 2025	8-K	Director or officer change	Oct 15, 2025	all files
Oct 7, 2025	4	Insider trade	Oct 3, 2025	all files
Oct 3, 2025	144	Notice of planned insider sale		all files
Sep 17, 2025	3	New insider	Sep 8, 2025	all files
Sep 4, 2025	8-K	Material agreement signed, New debt or obligation, Other events	Sep 4, 2025	all files
Sep 4, 2025	424B5	Prospectus		all files
Sep 3, 2025	4	Insider trade	Aug 29, 2025	all files
Sep 3, 2025	4	Insider trade	Aug 29, 2025	all files
Sep 3, 2025	FWP	Offering terms		all files
Sep 2, 2025	424B5	Prospectus		all files
Sep 2, 2025	S-3ASR	Shelf registration		all files
Sep 2, 2025	8-K	Regulation FD disclosure	Sep 2, 2025	all files
Aug 19, 2025	4	Insider trade	Aug 15, 2025	all files
Aug 15, 2025	144	Notice of planned insider sale		all files
Aug 12, 2025	144	Notice of planned insider sale		all files
Jul 31, 2025	10-Q	Quarterly report	Jun 30, 2025	all files · tables
Jul 31, 2025	8-K	Quarterly results	Jul 31, 2025	all files
Jul 28, 2025	8-K/A	Director or officer change	May 30, 2025	all files
Jun 27, 2025	11-K	Employee plan annual report	Dec 31, 2024	all files
Jun 4, 2025	4	Insider trade	Jun 2, 2025	all files
Jun 3, 2025	3	New insider	Jun 2, 2025	all files
Jun 3, 2025	4	Insider trade	May 30, 2025	all files
Jun 2, 2025	8-K	Director or officer change	May 30, 2025	all files
May 20, 2025	8-K	Regulation FD disclosure	May 20, 2025	all files
May 9, 2025	144	Notice of planned insider sale		all files
May 8, 2025	144	Notice of planned insider sale		all files
May 7, 2025	144	Notice of planned insider sale		all files
May 6, 2025	144	Notice of planned insider sale		all files
May 5, 2025	144	Notice of planned insider sale		all files
May 2, 2025	10-Q	Quarterly report	Mar 31, 2025	all files · tables
May 2, 2025	8-K	Quarterly results	May 2, 2025	all files

Show the other 75 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Sources

SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.

Also

Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CI/export.csv") into a cell.

Next:Earnings releases